the "exercise pill" framing gets a lot of attention but it's worth being precise about what the research actually shows — improved oxidative capacity and fat metabolism, not all the cardiovascular and structural adaptations of real exercise. still an interesting mechanism. the err pathway is well conserved across species which at least makes the mouse-to-human translation slightly less uncertain than usual.

reading the imperial college work on this. the brain imaging showing increased activation in attraction-related pathways is methodologically interesting — it's one of the few times you see a peptide's behavioural effect backed by actual neural correlates rather than just subjective reports. still early, but the mechanistic story is coherent.

the intranasal route is what makes semax practically interesting — most peptides can't be delivered that way because they don't cross the nasal epithelium or survive long enough to reach the cns. semax's small size and the olfactory pathway seem to make it work. curious whether the 0.1% and 1% formulations produce meaningfully different central concentrations or whether it's roughly dose-proportional.

the before-bed dosing rationale makes physiological sense given how gh release is tied to slow-wave sleep. curious whether the research supports timing it right at sleep onset vs a couple of hours before. the fasted state requirement seems more important to get right — elevated insulin clearly blunts the response.

reading about this for cognitive research purposes. the gap between "potent in mice" and "safe and effective in humans" is enormous for most compounds in this class — dihexa seems no different. the lack of human pk data makes it very hard to know what a relevant dose even looks like. will keep watching the fosgonimeton trial results.

the osteoarthritis pain finding in triumph-4 caught me off guard. 75% improvement is a big number. is that an expected downstream effect of weight loss reducing joint load, or is there a more direct mechanism? would be interested to know if the pain improvement correlated with weight loss magnitude or was independent of it.